Log In
BCIQ
Print this Print this
 

Aplenzin, bupropion hydrobromide (formerly BVF-033)

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionOnce-daily alcohol-resistant formulation of buproprion
Molecular Target Dopamine transporter ; Norepinephrine transporter
Mechanism of ActionDopamine and norepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDepression
Indication DetailsTreat depression
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/05/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today